Acadian Asset Management
WX

Acadian Asset Management’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Acadian Asset Management’s Portfolio WX Stock Details WX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-235,752
Closed -$10.2M – 1602
2015
Q3 		$10.2M Sell
235,752
-515,294
-69% -$21.7M 0.06% 285
2015
Q2 		$31.7M Sell
751,046
-600,051
-44% -$25.3M 0.15% 157
2015
Q1 		$52.4M Buy
1,351,097
+29,017
+2% +$1.12M 0.24% 117
2014
Q4 		$44.5M Buy
1,322,080
+24,959
+2% +$882K 0.2% 135
2014
Q3 		$45.4M Sell
1,297,121
-734,231
-36% -$25.2M 0.22% 135
2014
Q2 		$66.8M Sell
2,031,352
-447,370
-18% -$15.3M 0.32% 78
2014
Q1 		$91.4M Buy
2,478,722
+1,809,127
+270% +$66.4M 0.48% 52
2013
Q4 		$25.7M Buy
669,595
+486,042
+265% +$15.3M 0.14% 145
2013
Q3 		$5.03M Buy
183,553
+12,625
+7% +$299K 0.03% 317
2013
Q2 		$3.59M Buy
+170,928
New +$3.34M 0.03% 331

Other funds holding WX

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
CCS
Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Acadian Asset Management's WX Position: Q4 2015 in Review

Acadian Asset Management sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 235,752 shares — an estimated $10.2M sold.

Acadian Asset Management first reported a position in WX in Q2 2013 and held it in 10 quarters. The position peaked at $91.4M in Q1 2014. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

  • Acadian Asset Management reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
  • Acadian Asset Management sold 235,752 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $10.2M.
  • Acadian Asset Management first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2013 and held it in 10 quarters.
  • Acadian Asset Management's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $91.4M in Q1 2014.
  • 2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Acadian Asset Management's 13F filing for Q4 2015, filed 14 Jan 2016.